Stay updated on Trastuzumab Emtansine Safety Extension in Prior Recipients Clinical Trial
Sign up to get notified when there's something new on the Trastuzumab Emtansine Safety Extension in Prior Recipients Clinical Trial page.

Latest updates to the Trastuzumab Emtansine Safety Extension in Prior Recipients Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedFooter revision tag updated from v3.5.3 to v3.5.4, signaling a new deployment of the site. This metadata change does not modify the study content or functionality.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedA site release/version indicator on the page was updated from **v3.5.2** to **v3.5.3**.SummaryDifference0.0%

- Check44 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.0%

- Check73 days agoChange DetectedFooter now displays Revision: v3.5.0, replacing Revision: v3.4.3.SummaryDifference0.0%

- Check87 days agoChange DetectedRevision history updated: added Revision: v3.4.3 and removed Revision: v3.4.2.SummaryDifference0.0%

- Check109 days agoChange DetectedFooter revision updated from v3.4.1 to v3.4.2; no impact on study content or history data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Trastuzumab Emtansine Safety Extension in Prior Recipients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Trastuzumab Emtansine Safety Extension in Prior Recipients Clinical Trial page.